EQL Pharma AB (publ) (STO:EQL)
Sweden · Delayed Price · Currency is SEK 57.80
+0.80 (1.40%)
At close: Dec 30, 2025
EQL Pharma AB Market Cap
EQL Pharma AB has a market cap or net worth of 1.71 billion as of December 31, 2025. Its market cap has decreased by -27.50% in one year.
Market Cap
1.71B
Enterprise Value
2.08B
Revenue
399.07M
Ranking
n/a
PE Ratio
59.27
Stock Price
57.80
Market Cap Chart
Since December 17, 2013, EQL Pharma AB's market cap has increased from 78.22M to 1.71B, an increase of 2,082.00%. That is a compound annual growth rate of 29.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 1.71B | -27.50% |
| Dec 30, 2024 | 2.35B | 142.51% |
| Dec 29, 2023 | 970.72M | 16.78% |
| Dec 30, 2022 | 831.22M | -26.29% |
| Dec 30, 2021 | 1.13B | -2.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.91B |
| Getinge AB | 59.27B |
| Sectra AB | 48.17B |
| Camurus AB | 37.07B |
| Medicover AB | 33.29B |
| Asker Healthcare Group AB | 32.59B |
| BioArctic AB | 27.78B |
| Elekta AB | 21.80B |